Ketek

Ketek antibiotic drug faces intense FDA scrutiny over liver failure reports

Thursday, November 16, 2006 by: Jerome Doulgas
Tags: Ketek, Sanofi-Aventis, the FDA

eTrust Pro Certified

Most Viewed Articles
Popular on Facebook
BACK INTO THE CLOSET: Why U.S. reporters are not allowed to write about rainbow events in nations where being gay is still condemned
Depopulation test run? 75% of children who received vaccines in Mexican town now dead or hospitalized
INVESTIGATION: Three days before Dr. Bradstreet was found dead in a river, U.S. govt. agents raided his research facility to seize a breakthrough cancer treatment called GcMAF
A family destroyed: Six-month-old dies after clinic injects baby with 13 vaccines at once without mother's informed consent
Biologist explains how marijuana causes tumor cells to commit suicide
BOMBSHELL: China and America already at war: Tianjin explosion carried out by Pentagon space weapon in retaliation for Yuan currency devaluation... Military helicopters now patrolling Beijing
Companies begin planting microchips under employees' skin
BAM! Chipotle goes 100% non-GMO; flatly rejecting the biotech industry and its toxic food ingredients
ECONOMIC SLAVERY FOR ALL: While we were distracted with the Confederate flag flap, Congress quietly forfeited our entire economic future via fast-track trade authority
McDonald's in global profit free fall as people everywhere increasingly reject chemically-altered toxic fast food
March Against Monsanto explodes globally... World citizens stage massive protests across 38 countries, 428 cities... mainstream media pretends it never happened
SCOTUS same-sex marriage decision may have just legalized the concealed carry of loaded firearms across all 50 states, nullifying gun laws everywhere
Vicious attack on Dr. Oz actually waged by biotech mafia; plot to destroy Oz launched after episode on glyphosate toxicity went viral
Nearly every mass shooting in the last 20 years shares one surprising thing? and it's not guns
Holistic cancer treatment pioneer Dr. Nicholas Gonzalez dies suddenly; patients mourn the loss of a compassionate, innovative doctor who helped thousands heal from cancer
Inuit Elders tell NASA Earth Axis Shifted
Wild eyes and bowl cuts: Why do mass shooters always share the same hair styles and crazed zombie stares?
Genetically white woman now claims self-identify as black: If you can choose your gender, can you also choose your race? What about your species? Can a human claim to be a llama?
Delicious
(NaturalNews) With reports of liver failure in a dozen patients and four associated deaths becoming public knowledge, U.S. health officials said this week that they plan to ask outside advisors if Ketek -- an antibiotic made by Sanofi-Aventis -- should continue to be allowed on the market.

In 2004, Ketek was approved by the FDA but has become a subject of a U.S. Senate Finance Committee investigation into whether the FDA's handling of Ketek's approval and possible use of faulty data was in error. FDA spokeswoman Laura Alvey said, "We will ask the committee if the overall risk/benefit profile supports continued marketing of Ketek for various indications."

A public meeting of outside officials who are experts on anti-infective drugs will be convened by the FDA in order to have Ketek discussed.

Alvey added that "a comprehensive analysis of all safety data for Ketek" will be considered. Ketek is approved to treat acute bacterial worsening of chronic bronchitis, acute bacterial sinusitis and community-acquired pneumonia.

Sanofi spokeswoman Lisa Kennedy said that the drug's parent company -- Sanofi-Aventis -- looked forward to discussing the data at the meeting. Kennedy had no comment on what action could be taken as a result of the meeting's outcome.

Kennedy added that "Based on the data available to us and after consultation with experts, we continue to believe the benefits of Ketek outweigh the risks when the drug is used as directed in its approved indication." Sales of Ketek for the first half of 2006 are estimated at $50 million according to data released this June by Sanofi-Aventis.

That same June, the FDA received reports of acute liver failure in Ketek patients, which included four deaths. A new warning on the drug's packaging and marketing was added in June as well.

Senate Finance Committee Chairman Charles Grassley, R-Iowa, stated "It's good to see the FDA doing due diligence with Ketek. The agency needs to do everything possible to make sure material information is not withheld from the advisory committee during this meeting," when asked about the upcoming outside panel meeting being organized by the FDA.

###

Follow real-time breaking news headlines on
Ketek at FETCH.news
Join over four million monthly readers. Your privacy is protected. Unsubscribe at any time.
comments powered by Disqus
Take Action: Support NaturalNews.com by linking back to this article from your website

Permalink to this article:

Embed article link: (copy HTML code below):

Reprinting this article:
Non-commercial use OK, cite NaturalNews.com with clickable link.

Follow Natural News on Facebook, Twitter, Google Plus, and Pinterest

Colloidal Silver

Advertise with NaturalNews...

Support NaturalNews Sponsors:

Advertise with NaturalNews...

GET SHOW DETAILS
+ a FREE GIFT

Sign up for the FREE Natural News Email Newsletter

Receive breaking news on GMOs, vaccines, fluoride, radiation protection, natural cures, food safety alerts and interviews with the world's top experts on natural health and more.

Join over 7 million monthly readers of NaturalNews.com, the internet's No. 1 natural health news site. (Source: Alexa.com)

Your email address *

Please enter the code you see above*

No Thanks

Already have it and love it!

Natural News supports and helps fund these organizations:

* Required. Once you click submit, we will send you an email asking you to confirm your free registration. Your privacy is assured and your information is kept confidential. You may unsubscribe at anytime.